ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99,338 | +15.6% | 11,250 | 0.0% | 0.02% | +16.7% |
| Q4 2022 | $85,950 | +7.4% | 11,250 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $80,000 | -12.1% | 11,250 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $91,000 | -71.2% | 11,250 | 0.0% | 0.02% | -64.4% |
| Q4 2021 | $316,000 | -17.3% | 11,250 | 0.0% | 0.06% | -24.4% |
| Q3 2021 | $382,000 | -70.7% | 11,250 | -65.3% | 0.08% | -72.3% |
| Q1 2021 | $1,304,000 | -48.6% | 32,388 | -24.5% | 0.28% | -55.1% |
| Q4 2020 | $2,538,000 | +63350.0% | 42,916 | -41.3% | 0.63% | -52.9% |
| Q3 2020 | $4,000 | -99.9% | 73,099 | -11.8% | 1.33% | +12.3% |
| Q2 2020 | $4,011,000 | +27.9% | 82,916 | -26.6% | 1.19% | +5.3% |
| Q1 2020 | $3,137,000 | – | 112,916 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |